Disproportionality analysis of hematologic adverse events associated with trastuzumab deruxtecan using the Japanese pharmacovigilance database

Clinical & Translational Oncology 2026

View at publisher

Authors: Yuko Kanbayashi, Risa Morioka, Koichi Takayama, Keiko Hosohata

DOI: 10.1007/s12094-026-04239-2

Cited by: 1

References: 30

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions HER2/EGFR in Cancer Research Chemotherapy-related skin toxicity

References 30